Blue Jet Healthcare Limited (BLUEJET.BO)
Blue Jet Healthcare Limited operates in the Biotechnology industry of the Healthcare sector, headquartered in Thane, MA, IN. The stock last traded at $584.10, down 1.82% on the session, giving a market capitalisation of $100.98B. Its beta of 0.64 implies it has historically moved less than the broad market.
Established in 1968 and based in Thane, India, Blue Jet Healthcare Limited is a key player in the pharmaceutical sector. The company primarily focuses on the manufacturing and sale of specialized chemical intermediates and active pharmaceutical ingredients (APIs), crucial components for a wide array of pharmaceutical and healthcare products. Its offerings encompass integrated intermediates for contrast media, saccharin and related salt compounds, alongside various niche pharmaceutical intermediates and APIs. Beyond product supply, Blue Jet also delivers comprehensive contract development and manufacturing (CDMO/CMO) solutions and associated development services. Demonstrating a broad global reach, the company conducts its business across India, Norway, the United States, Sweden, Italy, and Spain, among other international markets.
Blue Jet Healthcare Limited is most often compared with the following Healthcare names: